OAKVILLE, ON, Sept. 25, 2012 /CNW/ - Watson Pharma Company today announced that Rapalfo® (silodosin), a new treatment for benign prostatic hyperplasia (BPH), is available in Canada. BPH is a common, ...
JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) — Prostate health is one of the most overlooked yet critical concerns for men over 40, yet most available solutions offer nothing but temporary relief or ...